New Drugs May Be Big Advance in Lung Cancer Care

MONDAY, April 16, 2018 (HealthDay News) — Drugs designed to trigger a patient’s immune system may help boost survival for those battling lung cancer, two new studies found. The first study found that when the immunotherapy drug Keytruda (pembrolizumab) was combined with standard chemotherapy, the chance that a patient would die within the next 11…